Home
PLRX
PLRX News

Latest Pliant Therapeutics Inc. (PLRX) News on February 22, 2025

Blade Air Mobility Leads The Charge Among 3 US Penny Stocks

Simply Wall St.

4 days ago

Blade Air Mobility Leads The Charge Among 3 US Penny Stocks

All You Need to Know About PLIANT THERAPT (PLRX) Rating Upgrade to Buy

Zacks

8 days ago

All You Need to Know About PLIANT THERAPT (PLRX) Rating Upgrade to Buy

MT Newswires

9 days ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

9 days ago

Pliant Therapeutics to Assemble Expert Panel to Review BEACON-IPF Trial Data; Shares Jump

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

BioPharma Dive

9 days ago

Neumora shakes up its C-suite; Biogen cuts early-stage pipeline

Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

GlobeNewswire

9 days ago

Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics downgraded to Neutral from Overweight at JPMorgan

TipRanks

11 days ago

Pliant Therapeutics downgraded to Neutral from Overweight at JPMorgan

MT Newswires

12 days ago

Sector Update: Health Care Stocks Retreat Monday Afternoon

MT Newswires

12 days ago

Top Midday Decliners

Pliant Therapeutics Pauses Enrollment in BEACON-IPF Trial, Shares Take Steep Dive

GuruFocus.com

12 days ago

Pliant Therapeutics Pauses Enrollment in BEACON-IPF Trial, Shares Take Steep Dive

MT Newswires

12 days ago

Pliant Therapeutics Shares Tumble Amid Analyst Downgrades Following Study Suspension

MT Newswires

12 days ago

Sector Update: Health Care Stocks Flat to Edging Higher Pre-Bell Monday

MT Newswires

12 days ago

Sector Update: Health Care

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

Benzinga

12 days ago

Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues

MT Newswires

12 days ago

Wells Fargo Downgrades Pliant Therapeutics to Equalweight From Overweight, $4 Price Target

MT Newswires

12 days ago

Citigroup Downgrades Pliant Therapeutics to Neutral From Buy, $4 Price Target

MT Newswires

12 days ago

HC Wainwright Downgrades Pliant Therapeutics to Neutral From Buy

MT Newswires

12 days ago

Oppenheimer Downgrades Pliant Therapeutics to Perform From Outperform

MT Newswires

12 days ago

RBC Downgrades Pliant Therapeutics to Sector Perform From Outperform, Cuts Price Target to $4 From $45, Keeps Speculative Risk

MT Newswires

12 days ago

Pliant Therapeutics Suspends Enrollment in Phase 2b Idiopathic Pulmonary Fibrosis Trial

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

GlobeNewswire

15 days ago

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a month ago

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer

GlobeNewswire

a month ago

Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer

Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 months ago

Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Pliant Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire

3 months ago

Pliant Therapeutics to Participate in Upcoming Investor Events

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

GlobeNewswire

3 months ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

GlobeNewswire

4 months ago

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024

GlobeNewswire

4 months ago

Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024

Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc

GuruFocus.com

5 months ago

Paradigm Biocapital Advisors LP Acquires New Stake in Pliant Therapeutics Inc

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

GlobeNewswire

5 months ago

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

GlobeNewswire

5 months ago

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024

GlobeNewswire

5 months ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

GlobeNewswire

6 months ago

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

Pliant Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire

6 months ago

Pliant Therapeutics to Participate in Upcoming Investor Events

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024

GlobeNewswire

6 months ago

Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024

MT Newswires

6 months ago

Oppenheimer Adjusts Pliant Therapeutics Price Target to $45 From $48, Maintains Outperform Rating

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire

6 months ago

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

GlobeNewswire

7 months ago

Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference

Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple Measures

GlobeNewswire

7 months ago

Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Continued Antifibrotic and Anti-Cholestatic Activity Displayed Across Multiple Measures

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

GlobeNewswire

8 months ago

Pliant Therapeutics Announces Appointment of Steve Krognes to Board of Directors

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

GlobeNewswire

8 months ago

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

Motley Fool

8 months ago

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

CNW Group

8 months ago

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

Investor's Business Daily

8 months ago

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

EPCOR and HAWSCo Enter Ownership Transfer Agreement

CNW Group

8 months ago

EPCOR and HAWSCo Enter Ownership Transfer Agreement

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

GlobeNewswire

8 months ago

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

Southwest Airlines stock pops on report of Elliott's $2B stake

Yahoo Finance Video

8 months ago

Southwest Airlines stock pops on report of Elliott's $2B stake

Business Wire

8 months ago

Form 8.3 - Virgin Money UK plc

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

GlobeNewswire

9 months ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™

Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

GlobeNewswire

9 months ago

Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

MT Newswires

9 months ago

Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial

Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis

GlobeNewswire

9 months ago

Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)

Simply Wall St.

9 months ago

Pliant Therapeutics First Quarter 2024 Earnings: US$0.78 loss per share (vs US$0.67 loss in 1Q 2023)

MT Newswires

10 months ago

Oppenheimer Adjusts Price Target on Pliant Therapeutics to $48 From $47, Maintains Outperform Rating

Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™

GlobeNewswire

10 months ago

Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™

MT Newswires

10 months ago

RBC Cuts Price Target on Pliant Therapeutics to $45 From $54, Keeps Outperform, Speculative Risk

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire

10 months ago

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

Pliant Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire

10 months ago

Pliant Therapeutics to Participate in Upcoming Investor Events

Pliant Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire

a year ago

Pliant Therapeutics to Participate in Upcoming Investor Events

Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference

GlobeNewswire

a year ago

Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference

Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis

GlobeNewswire

a year ago

Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis

Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

Zacks

a year ago

Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results

GlobeNewswire

a year ago

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results

Pliant Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Pliant Therapeutics to Participate in Upcoming Investor Conferences

Pliant Therapeutics to Participate in Upcoming Investor Events

GlobeNewswire

a year ago

Pliant Therapeutics to Participate in Upcoming Investor Events

Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

GlobeNewswire

a year ago

Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

15 Highest Quality Fast Food Burgers in the US

Insider Monkey

a year ago

15 Highest Quality Fast Food Burgers in the US

Del Taco Partners With Stone Brewing to Elevate Beer Battered Crispy Fish Tacos

GlobeNewswire

a year ago

Del Taco Partners With Stone Brewing to Elevate Beer Battered Crispy Fish Tacos

Triumph Group (TGI) Earnings Expected to Grow: Should You Buy?

Zacks

a year ago

Triumph Group (TGI) Earnings Expected to Grow: Should You Buy?

Eastman (EMN) and Swiss Eyewear to Launch INVU Collection

Zacks

a year ago

Eastman (EMN) and Swiss Eyewear to Launch INVU Collection

Recent Price Trend in Vericel Corporation (VCEL) is Your Friend, Here's Why

Zacks

a year ago

Recent Price Trend in Vericel Corporation (VCEL) is Your Friend, Here's Why

3 Momentum Anomaly Stocks to Bet on Amid Market Volatility

Zacks

a year ago

3 Momentum Anomaly Stocks to Bet on Amid Market Volatility

Return Trends At John Wiley & Sons (NYSE:WLY) Aren't Appealing

Simply Wall St.

a year ago

Return Trends At John Wiley & Sons (NYSE:WLY) Aren't Appealing

CXW: Believe New Contract Wins Support Outlook for Continued Occupancy, Operating Improvements

Zacks Small Cap Research

a year ago

CXW: Believe New Contract Wins Support Outlook for Continued Occupancy, Operating Improvements

Baillie Gifford Adjusts Position in Sweetgreen Inc

GuruFocus.com

a year ago

Baillie Gifford Adjusts Position in Sweetgreen Inc

S&T Bancorp, Inc. (NASDAQ:STBA) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

S&T Bancorp, Inc. (NASDAQ:STBA) Q4 2023 Earnings Call Transcript

Should You Think About Buying Lumen Technologies, Inc. (NYSE:LUMN) Now?

Simply Wall St.

a year ago

Should You Think About Buying Lumen Technologies, Inc. (NYSE:LUMN) Now?

Down Over 30%, This Magnificent Growth Stock Looks Like a Screaming Buy

Motley Fool

a year ago

Down Over 30%, This Magnificent Growth Stock Looks Like a Screaming Buy

Trustmark Corporation (NASDAQ:TRMK) Analysts Are Pretty Bullish On The Stock After Recent Results

Simply Wall St.

a year ago

Trustmark Corporation (NASDAQ:TRMK) Analysts Are Pretty Bullish On The Stock After Recent Results

S&T Bancorp (STBA) Q4 Earnings and Revenues Top Estimates

Zacks

a year ago

S&T Bancorp (STBA) Q4 Earnings and Revenues Top Estimates

NetScout Systems Inc (NTCT) Faces Headwinds: A Dive into Q3 FY24 Earnings

GuruFocus.com

a year ago

NetScout Systems Inc (NTCT) Faces Headwinds: A Dive into Q3 FY24 Earnings

New Analyst Coverage: 3 Stocks in Focus for Higher Returns

Zacks

a year ago

New Analyst Coverage: 3 Stocks in Focus for Higher Returns

Want $600 in Super Safe Dividend Income in 2024? Invest $8,000 Into the Following 3 Ultra-High-Yield Stocks.

Motley Fool

a year ago

Want $600 in Super Safe Dividend Income in 2024? Invest $8,000 Into the Following 3 Ultra-High-Yield Stocks.

Winners And Losers Of Q3: MongoDB (NASDAQ:MDB) Vs The Rest Of The Data Storage Stocks

StockStory

a year ago

Winners And Losers Of Q3: MongoDB (NASDAQ:MDB) Vs The Rest Of The Data Storage Stocks

Unpacking Q3 Earnings: Commvault Systems (NASDAQ:CVLT) In The Context Of Other Data Storage Stocks

StockStory

a year ago

Unpacking Q3 Earnings: Commvault Systems (NASDAQ:CVLT) In The Context Of Other Data Storage Stocks

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest

StockStory

a year ago

Online Marketplace Stocks Q3 Teardown: Shutterstock (NYSE:SSTK) Vs The Rest

Solar Stocks Enphase, Sunnova Jump On Upgrade. Why Analyst Sees Upside After Rough Year.

Investor's Business Daily

a year ago

Solar Stocks Enphase, Sunnova Jump On Upgrade. Why Analyst Sees Upside After Rough Year.

Ahead of Stellar Bancorp (STEL) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

a year ago

Ahead of Stellar Bancorp (STEL) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Columbus McKinnon Declares Quarterly Dividend of $0.07 per Share

Business Wire

a year ago

Columbus McKinnon Declares Quarterly Dividend of $0.07 per Share

LTC Properties Inc's Dividend Analysis

GuruFocus.com

a year ago

LTC Properties Inc's Dividend Analysis

TipRanks’ ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Top-Scoring Stocks

TipRanks

a year ago

TipRanks’ ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Top-Scoring Stocks

Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares

GuruFocus.com

a year ago

Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares

Associated Press Finance

a year ago

Nicolet Bankshares: Q4 Earnings Snapshot

Nicolet Bankshares, Inc. Announces 2023 Results

Business Wire

a year ago

Nicolet Bankshares, Inc. Announces 2023 Results

CoreCivic (NYSE:CXW) May Have Issues Allocating Its Capital

Simply Wall St.

a year ago

CoreCivic (NYSE:CXW) May Have Issues Allocating Its Capital

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Central Puerto SA's Dividend Analysis

GuruFocus.com

a year ago

Central Puerto SA's Dividend Analysis

Share on Social Networks: